Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-19

FDA Approved: CARBOPROST TROMETHAMINE — Original Application (SOLA Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved an original application for Carboprost tromethamine by SOLA Pharmaceuticals, LLC, a generic prostaglandin used to terminate pregnancy and to contro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPROST TROMETHAMINE (CARBOPROST TROMETHAMINE)

Snippet

ORIG AP for CARBOPROST TROMETHAMINE (CARBOPROST TROMETHAMINE)